中文
English
HOME
TECHNOLOGY
PIPELINE
NEWS
PUBLICATIONS
COMPANY
CAREERS
A new paradigm of mechanism- and patient-centered pharmaceutical research and development
New Mechanism, New Target Drug Pipelines
Disease
Type of drug
Project code
Data-driven target discovery
Target validation
Drug synthesis
Preclinical studies
IND-enabling
Pancreatic cancer
Small molecules
ZY0001
Pan-cancer
Biologics
ZY0002
Pancreatic cancer
Small molecules
ZY0003
Drug Repurposing Pipelines
Drug field
Project code
Data-driven drug repurposing
Biological evidence
Clinical evidence
Patent application
Approved
CDK4/6 inhibitors
ZYNI001
PARP inhibitors
ZYNI002
Anti-tumor drugs
ZYNI003
Undisclosed
Anti-tumor drugs
ZYNI004
Undisclosed
Anti-tumor drugs
ZYNI005
Undisclosed
Precision Medical Products Pipelines
Disease
Project
Data-driven new insights
Patent application
Clinical trials registration
Approved
Marketing
Liver cancer
Companion diagnostics
Breast cancer
Precision pathological classification
Breast cancer
Very early accurate diagnosis
Clinical Research Programs
Diseases
Research direction
Establishment of mechanistic models
Clinical study design
Patient recruitment
Model adjustment and validation
New scientific insights
Patent application
Model validation
New pipeline development
Breast cancer
Study on the pathogenesis of triple negative breast cancer based on germline genome
Liver cancer
Establish the applicability method of HAI-FOLFOX in patients with liver cancer
Breast cancer
Study on germline genomic etiology and early prevention of breast cancer
Pansolid tumor
Clinical research on drug repurposing and companion diagnostics
Lung cancer
Study the mechanism of brain metastasis of lung adenocarcinoma
Solid tumor
Study the precise distribution mechanism of targeted drugs
Solid tumor
Study the precise distribution mechanism of targeted drugs
扫一扫关注公众号